{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:02:14Z","timestamp":1784772134262,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.cyto.2014.06.008","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T13:16:02Z","timestamp":1403788562000},"page":"289-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Increased levels of serum galectin-3 in patients with primary Sj\u00f6gren\u2019s syndrome: Associated with interstitial lung disease"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6967-8595","authenticated-orcid":false,"given":"Rong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangyue","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachen","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2014.06.008_b0005","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.4049\/jimmunol.152.11.5532","article-title":"Cytokine mRNA expression in salivary gland biopsies of Sj\u00f6gren\u2019s syndrome","volume":"152","author":"Fox","year":"1994","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2014.06.008_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2249.2012.04587.x","article-title":"Cytokine\/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sj\u00f6gren\u2019s syndrome","volume":"169","author":"Moriyama","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2014.06.008_b0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nri2536","article-title":"Turning \u2018sweet\u2019 on immunity: galectin\u2013glycan interactions in immune tolerance and inflammation","volume":"9","author":"Rabinovich","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2014.06.008_b0020","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/art.24574","article-title":"Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways","volume":"60","author":"Filer","year":"2009","journal-title":"Arthrit Rheum"},{"issue":"1","key":"10.1016\/j.cyto.2014.06.008_b0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00798.x","article-title":"Galectin-3 regulates T-cell functions","volume":"230","author":"Hsu","year":"2009","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.cyto.2014.06.008_b0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0961203308094361","article-title":"Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis","volume":"18","author":"Kang","year":"2009","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.cyto.2014.06.008_b0035","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1468-3083.2010.03941.x","article-title":"Serum galectin-3 levels in patients with Beh\u00e7et\u2019s disease: association with disease activity over a long-term follow-up","volume":"25","author":"\u00d6zden","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.cyto.2014.06.008_b0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2332\/allergolint.O-06-449","article-title":"Role of Galectin-3 in Human Pulmonary Fibrosis","volume":"56","author":"Nishi","year":"2007","journal-title":"Allergol Int"},{"issue":"4","key":"10.1016\/j.cyto.2014.06.008_b0045","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1189\/jlb.69.4.555","article-title":"Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes","volume":"69","author":"Joo","year":"2001","journal-title":"J Leukocyte Biol"},{"issue":"3","key":"10.1016\/j.cyto.2014.06.008_b0050","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2353\/ajpath.2009.090319","article-title":"Systemic and local interleukin-17 and linked cytokines associated with Sj\u00f6gren\u2019s syndrome immunopathogenesis","volume":"175","author":"Katsifis","year":"2009","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.cyto.2014.06.008_b0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4081\/reumatismo.2013.192","article-title":"IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sj\u00f6gren\u2019s syndrome","volume":"65","author":"Alunno","year":"2013","journal-title":"Reumatismo"},{"issue":"1","key":"10.1016\/j.cyto.2014.06.008_b0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/187152810791292935","article-title":"Emerging treatment strategies and potential therapeutic targets in primary Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Becker","year":"2010","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"6","key":"10.1016\/j.cyto.2014.06.008_b0065","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.cyto.2014.06.008_b0070","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1756-185X.2011.01632.x","article-title":"Elevated production of galectin-3 is correlated with juvenile idiopathic arthritis disease activity, severity, and progression","volume":"14","author":"Ezzat","year":"2011","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"10.1016\/j.cyto.2014.06.008_b0075","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2353\/ajpath.2008.070726","article-title":"Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis","volume":"172","author":"Henderson","year":"2008","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.cyto.2014.06.008_b0080","first-page":"513","article-title":"Serum interleukin-17 & nitric oxide levels in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"135","author":"Miletic","year":"2012","journal-title":"Indian J Med Res"},{"issue":"2","key":"10.1016\/j.cyto.2014.06.008_b0085","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.30118","article-title":"Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis","volume":"63","author":"Forsman","year":"2011","journal-title":"Arthrit Rheum"},{"issue":"2","key":"10.1016\/j.cyto.2014.06.008_b0090","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.4049\/jimmunol.182.2.1167","article-title":"Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis","volume":"182","author":"Jiang","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2014.06.008_b0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cyto.2011.06.001","article-title":"Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function","volume":"55","author":"Wanninger","year":"2011","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.cyto.2014.06.008_b0100","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1378\/chest.08-0754","article-title":"Serum albumin concentration and waiting list mortality in idiopathic interstitial pneumonia","volume":"135","author":"Zisman","year":"2009","journal-title":"Chest"},{"issue":"4\u20135","key":"10.1016\/j.cyto.2014.06.008_b0105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.humimm.2006.02.026","article-title":"Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies","volume":"67","author":"Magro","year":"2006","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2014.06.008_b0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin Immunopathol"},{"issue":"9","key":"10.1016\/j.cyto.2014.06.008_b0115","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1084\/jem.20090121","article-title":"Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response","volume":"207","author":"Markowska","year":"2009","journal-title":"J Exp Med"},{"issue":"34","key":"10.1016\/j.cyto.2014.06.008_b0120","doi-asserted-by":"crossref","first-page":"29913","DOI":"10.1074\/jbc.M111.226423","article-title":"Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor-2 in human endothelial cells","volume":"286","author":"Markowska","year":"2011","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.cyto.2014.06.008_b0125","doi-asserted-by":"crossref","first-page":"e52430","DOI":"10.1371\/journal.pone.0052430","article-title":"The two endocytic pathways mediated by the carbohydrate recognition domain and regulated by the collagen-like domain of galectin-3 in vascular endothelial cells","volume":"7","author":"Gao","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cyto.2014.06.008_b0130","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4049\/jimmunol.168.4.1813","article-title":"Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia","volume":"168","author":"Sato","year":"2002","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2014.06.008_b0135","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3899\/jrheum.110755","article-title":"Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis","volume":"39","author":"Taniguchi","year":"2012","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.cyto.2014.06.008_b0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1164\/rccm.201106-0965OC","article-title":"Regulation of transforming growth factor-\u03b21-driven lung fibrosis by galectin-3","volume":"185","author":"Mackinnon","year":"2012","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614001689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614001689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T16:08:01Z","timestamp":1689350881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466614001689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1043466614001689"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2014.06.008","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased levels of serum galectin-3 in patients with primary Sj\u00f6gren\u2019s syndrome: Associated with interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2014.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}